U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07214675) titled 'The Edison System for Treatment of Benign Prostatic Hyperplasia (BPH) Using Histotripsy' on Oct. 03.
Brief Summary: The purpose of this trial is to evaluate the safety of histotripsy using the HistoSonics Edison System for treatment of BPH.
Study Start Date: March, 2026
Study Type: INTERVENTIONAL
Condition:
Benign Prostatic Hyperplasia
Intervention:
DEVICE: HistoSonics Edison System
The HistoSonics Edison System is intended for the non-invasive mechanical destruction of prostate tissue for the treatment of BPH using histotripsy, a non-thermal, mechanical process of focused ultrasound.
Recruitment Status: NOT_YET_RECRUITING
...